We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK First Pharma Company to Contribute to NCI Bioinformatics Grid
GSK First Pharma Company to Contribute to NCI Bioinformatics Grid
June 20, 2008
Genomic profiling data from more than 300 cancer cell lines that GlaxoSmithKline (GSK) generated from preclinical research are now available in the National Cancer Institute’s (NCI) cancer Biomedical Informatics Grid (caBIG).